Blueprint Medicines Corp (BPMC) — Cash Flow Quality Index
Blueprint Medicines Corp (BPMC) has a Cash Flow Quality Index of -109.84x as of March 2025. Operating cash flow of $-54.48 Million is below net income of $496.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Blueprint Medicines Corp generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Blueprint Medicines Corp Cash Flow Quality Index (2020–2020)
Historical Cash Flow Quality Index for Blueprint Medicines Corp across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BPMC capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Blueprint Medicines Corp (2020–2020)
Year-by-year earnings quality comparison for Blueprint Medicines Corp. For live market cap and the full company financial profile, see BPMC market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1.23x | $387.04 Million | $313.88 Million | — |